Clinical Trial Detail

NCT ID NCT02043678
Title Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Bayer
Indications

prostate adenocarcinoma

Therapies

Prednisone

Abiraterone

Radium Ra 223 dichloride

Age Groups: adult

No variant requirements are available.